DFFN Annual FCF
-$14.97 M
-$467.30 K-3.22%
31 December 2022
Summary:
As of January 24, 2025, DFFN annual free cash flow is -$14.97 million, with the most recent change of -$467.30 thousand (-3.22%) on December 31, 2022. During the last 3 years, it has fallen by -$5.11 million (-51.84%).DFFN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN Quarterly FCF
-$2.65 M
+$2.32 M+46.74%
30 June 2023
Summary:
As of January 24, 2025, DFFN quarterly free cash flow is -$2.65 million, with the most recent change of +$2.32 million (+46.74%) on June 30, 2023. Over the past year, it has increased by +$1.36 million (+33.97%).DFFN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN TTM FCF
-$13.85 M
+$1.36 M+8.95%
30 June 2023
Summary:
As of January 24, 2025, DFFN TTM free cash flow is -$13.85 million, with the most recent change of +$1.36 million (+8.95%) on June 30, 2023. Over the past year, it has increased by +$888.80 thousand (+6.03%).DFFN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.2% | +34.0% | +6.0% |
| 3 y3 years | -51.8% | +15.8% | -23.2% |
| 5 y5 years | -17.1% | -4.2% | -40.5% |
DFFN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -626.0% | -9132.1% |
Diffusion Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$2.65 M(-46.7%) | -$13.85 M(-9.0%) |
| Mar 2023 | - | -$4.97 M(+43.0%) | -$15.21 M(+1.6%) |
| Dec 2022 | -$14.97 M(+3.2%) | -$3.47 M(+25.9%) | -$14.97 M(+3.1%) |
| Sept 2022 | - | -$2.76 M(-31.2%) | -$14.52 M(-1.5%) |
| June 2022 | - | -$4.01 M(-15.3%) | -$14.73 M(+4.8%) |
| Mar 2022 | - | -$4.73 M(+56.3%) | -$14.06 M(-3.1%) |
| Dec 2021 | -$14.50 M(+7.0%) | -$3.03 M(+1.8%) | -$14.50 M(-2.5%) |
| Sept 2021 | - | -$2.97 M(-10.7%) | -$14.87 M(-3.5%) |
| June 2021 | - | -$3.33 M(-35.7%) | -$15.41 M(+1.2%) |
| Mar 2021 | - | -$5.18 M(+52.5%) | -$15.22 M(+12.3%) |
| Dec 2020 | -$13.55 M(+37.5%) | -$3.39 M(-3.3%) | -$13.55 M(+7.6%) |
| Sept 2020 | - | -$3.51 M(+11.7%) | -$12.60 M(+12.1%) |
| June 2020 | - | -$3.14 M(-10.3%) | -$11.24 M(+5.0%) |
| Mar 2020 | - | -$3.50 M(+43.7%) | -$10.71 M(+8.6%) |
| Dec 2019 | -$9.86 M(-8.5%) | -$2.44 M(+13.2%) | -$9.86 M(-5.6%) |
| Sept 2019 | - | -$2.15 M(-17.5%) | -$10.45 M(+2.3%) |
| June 2019 | - | -$2.61 M(-1.8%) | -$10.21 M(+0.7%) |
| Mar 2019 | - | -$2.66 M(-12.2%) | -$10.14 M(-5.9%) |
| Dec 2018 | -$10.77 M(-15.7%) | -$3.03 M(+58.0%) | -$10.77 M(+7.3%) |
| Sept 2018 | - | -$1.92 M(-24.6%) | -$10.04 M(-18.9%) |
| June 2018 | - | -$2.54 M(-22.8%) | -$12.38 M(-2.1%) |
| Mar 2018 | - | -$3.29 M(+43.5%) | -$12.65 M(-1.0%) |
| Dec 2017 | -$12.78 M(+18.7%) | -$2.29 M(-46.2%) | -$12.78 M(+7.4%) |
| Sept 2017 | - | -$4.26 M(+52.0%) | -$11.90 M(+25.2%) |
| June 2017 | - | -$2.80 M(-18.1%) | -$9.50 M(-0.6%) |
| Mar 2017 | - | -$3.42 M(+142.0%) | -$9.56 M(-11.2%) |
| Dec 2016 | -$10.77 M(+106.1%) | -$1.41 M(-24.2%) | -$10.77 M(-7.5%) |
| Sept 2016 | - | -$1.86 M(-34.8%) | -$11.65 M(+8.2%) |
| June 2016 | - | -$2.86 M(-38.3%) | -$10.77 M(+20.8%) |
| Mar 2016 | - | -$4.63 M(+102.1%) | -$8.92 M(+70.6%) |
| Dec 2015 | -$5.23 M(-42.5%) | -$2.29 M(+132.9%) | -$5.23 M(+7.5%) |
| Sept 2015 | - | -$984.40 K(-2.3%) | -$4.86 M(-17.0%) |
| June 2015 | - | -$1.01 M(+7.1%) | -$5.86 M(-38.6%) |
| Mar 2015 | - | -$941.00 K(-51.2%) | -$9.54 M(+5.6%) |
| Dec 2014 | -$9.08 M | -$1.93 M(-2.5%) | -$9.03 M(+27.2%) |
| Sept 2014 | - | -$1.98 M(-57.8%) | -$7.10 M(+30.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$4.69 M(+983.0%) | -$5.45 M(+316.0%) |
| Mar 2014 | - | -$432.90 K(>+9900.0%) | -$1.31 M(+10.7%) |
| Dec 2013 | -$1.18 M(-72.5%) | -$600.00(-99.8%) | -$1.18 M(-55.8%) |
| Sept 2013 | - | -$333.00 K(-38.9%) | -$2.68 M(-7.8%) |
| June 2013 | - | -$544.80 K(+77.9%) | -$2.91 M(+5.0%) |
| Mar 2013 | - | -$306.20 K(-79.6%) | -$2.77 M(-35.7%) |
| Dec 2012 | -$4.31 M(-64.5%) | -$1.50 M(+167.8%) | -$4.31 M(-28.5%) |
| Sept 2012 | - | -$559.30 K(+37.3%) | -$6.03 M(-39.5%) |
| June 2012 | - | -$407.30 K(-77.9%) | -$9.97 M(-25.7%) |
| Mar 2012 | - | -$1.85 M(-42.6%) | -$13.42 M(+10.5%) |
| Dec 2011 | -$12.15 M(+509.1%) | -$3.22 M(-28.5%) | -$12.15 M(+30.2%) |
| Sept 2011 | - | -$4.50 M(+16.7%) | -$9.33 M(+67.4%) |
| June 2011 | - | -$3.86 M(+574.4%) | -$5.57 M(+152.2%) |
| Mar 2011 | - | -$572.20 K(+42.4%) | -$2.21 M(+10.8%) |
| Dec 2010 | -$1.99 M(+88.5%) | -$401.80 K(-45.8%) | -$1.99 M(+8.2%) |
| Sept 2010 | - | -$741.90 K(+50.0%) | -$1.84 M(+32.2%) |
| June 2010 | - | -$494.60 K(+38.8%) | -$1.40 M(+6.1%) |
| Mar 2010 | - | -$356.40 K(+42.0%) | -$1.31 M(+24.2%) |
| Dec 2009 | -$1.06 M(+109.1%) | -$250.90 K(-14.4%) | -$1.06 M(+9.8%) |
| Sept 2009 | - | -$293.20 K(-29.2%) | -$963.60 K(+34.9%) |
| June 2009 | - | -$413.90 K(+313.1%) | -$714.30 K(+40.3%) |
| Mar 2009 | - | -$100.20 K(-35.9%) | -$509.10 K(+0.6%) |
| Dec 2008 | -$506.00 K(<-9900.0%) | -$156.30 K(+256.0%) | -$506.00 K(-430.1%) |
| Sept 2008 | - | -$43.90 K(-79.0%) | $153.30 K(-363.4%) |
| June 2008 | - | -$208.70 K(+114.9%) | -$58.20 K(-931.4%) |
| Mar 2008 | - | -$97.10 K(-119.3%) | $7000.00(-7100.0%) |
| Dec 2007 | $0.00(0.0%) | $503.00 K(-296.9%) | -$100.00(-100.0%) |
| Sept 2007 | - | -$255.40 K(+78.0%) | -$503.10 K(+103.1%) |
| June 2007 | - | -$143.50 K(+37.7%) | -$247.70 K(+137.7%) |
| Mar 2007 | - | -$104.20 K(<-9900.0%) | -$104.20 K(<-9900.0%) |
| Dec 2006 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00 | $0.00 |
| Dec 2005 | -$75.00 K(-99.2%) | - | - |
| Dec 1999 | -$9.27 M(+20.3%) | - | - |
| Dec 1998 | -$7.70 M | - | - |
FAQ
- What is Diffusion Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual FCF year-on-year change?
- What is Diffusion Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly FCF year-on-year change?
- What is Diffusion Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals TTM FCF year-on-year change?
What is Diffusion Pharmaceuticals annual free cash flow?
The current annual FCF of DFFN is -$14.97 M
What is the all time high annual FCF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual free cash flow is $0.00
What is Diffusion Pharmaceuticals annual FCF year-on-year change?
Over the past year, DFFN annual free cash flow has changed by -$467.30 K (-3.22%)
What is Diffusion Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of DFFN is -$2.65 M
What is the all time high quarterly FCF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly free cash flow is $503.00 K
What is Diffusion Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, DFFN quarterly free cash flow has changed by +$1.36 M (+33.97%)
What is Diffusion Pharmaceuticals TTM free cash flow?
The current TTM FCF of DFFN is -$13.85 M
What is the all time high TTM FCF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high TTM free cash flow is $153.30 K
What is Diffusion Pharmaceuticals TTM FCF year-on-year change?
Over the past year, DFFN TTM free cash flow has changed by +$888.80 K (+6.03%)